Ortanol (Omeprazole)

Omeprazole, the active ingredient in Ortanol, is a proton pump inhibitor presented as a oral dosage form for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults. GNH USA supplies Ortanol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ortanol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ortanol is a proton pump inhibitor that acts on the acid‑secreting pathway of the stomach.

- Gastro‑oesophageal reflux disease (GERD): Improves symptom relief and promotes healing of esophageal irritation. - Peptic ulcer disease: Facilitates ulcer healing and reduces recurrence risk. - NSAID‑induced gastric ulcer: Provides gastro‑protection for patients on non‑steroidal anti‑inflammatory drugs. - Helicobacter pylori eradication (in combination therapy): Enhances bacterial eradication when used with antibiotics.

Common Side Effects: - Headache  - Diarr  - Nausea  - Abdominal t - Const  g -                   g    t \\  \nSerious or  t \\\